Effects of p53 Mutants on MDM2 Gene in Lung Cancer
Author Information
Author(s): VG Gorgoulis, PV Zacharatos, E Manolis, JA Ikonomopoulos, A Damalas, C Lamprinopoulos, GZ Rassidakis, V Zoumpourlis, A Kotsinas, AN Rassidakis, TD Halazonetis, C Kittas
Primary Institution: University of Athens, School of Medicine
Hypothesis
The study investigates whether mutant p53 proteins derived from lung carcinomas can bind to the p53-responsive element of the MDM2 gene and how this correlates with MDM2 expression.
Conclusion
The study suggests that certain p53 mutants may enhance MDM2 expression, indicating a potential 'gain of function' phenotype in lung carcinomas.
Supporting Evidence
- Mutant p53 proteins were shown to bind to the MDM2-p53RE in some cases.
- Certain p53 mutants enhanced the expression of the luciferase reporter gene.
- MDM2 protein isoforms were overexpressed in cases with DNA-binding activity.
Takeaway
Some changes in the p53 gene can make cancer cells behave more aggressively by affecting how they interact with another gene called MDM2.
Methodology
The study involved examining 12 cases of bronchogenic carcinomas for the ability of expressed mutant p53 to bind the MDM2-p53RE and correlating findings with MDM2 expression.
Limitations
The study is limited by the small sample size and the specific selection criteria for the cases examined.
Want to read the original?
Access the complete publication on the publisher's website